Search company, investor...

Stage

Loan | Alive

Total Raised

$680K

Last Raised

$680K | 4 yrs ago

About Celonova Biosciences

CeloNova BioSciences is a global medical device company that develops, manufactures and markets a family of interventional cardiology and endovascular products, including its proprietary COBRA PzF Coronary Stent System. The company's interventional cardiology and endovascular products are currently available in more than fifty countries.

Headquarters Location

8023 Vantage Dr. Suite 1500

San Antonio, Texas, 78230,

United States

210-489-4000

Loading...

Loading...

Celonova Biosciences Patents

Celonova Biosciences has filed 25 patents.

The 3 most popular patent topics include:

  • dosage forms
  • drug delivery devices
  • implants (medicine)
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/15/2016

7/6/2021

Dosage forms, Drug delivery devices, Routes of administration, Medical equipment, Pharmacokinetics

Grant

Application Date

11/15/2016

Grant Date

7/6/2021

Title

Related Topics

Dosage forms, Drug delivery devices, Routes of administration, Medical equipment, Pharmacokinetics

Status

Grant

Latest Celonova Biosciences News

Celonova Biosciences Inc’ COBRA in Italy: pricing trends

Jul 15, 2023

The COBRA is sold by Celonova Biosciences Inc in the Coronary Stents – BMS market. Bare metal stents (BMS) are uncoated stents that are permanently placed inside the artery. These stents are constructed from a range of metals, including nitinol, stainless steel, and cobalt chromium. Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements. For a complete picture of Celonova Biosciences Inc’ Coronary Stents – BMS device pricing in Italy, buy the report here. Subscribe to our Newsletter

Celonova Biosciences Frequently Asked Questions (FAQ)

  • Where is Celonova Biosciences's headquarters?

    Celonova Biosciences's headquarters is located at 8023 Vantage Dr., San Antonio.

  • What is Celonova Biosciences's latest funding round?

    Celonova Biosciences's latest funding round is Loan.

  • How much did Celonova Biosciences raise?

    Celonova Biosciences raised a total of $680K.

  • Who are the investors of Celonova Biosciences?

    Investors of Celonova Biosciences include Paycheck Protection Program and Clayton Associates.

  • Who are Celonova Biosciences's competitors?

    Competitors of Celonova Biosciences include Moximed, Cerapedics, Lensar , Novate Medical, LinguaFlex and 7 more.

Loading...

Compare Celonova Biosciences to Competitors

N
NeuroTrax

NeuroTrax is a company focused on brain health, operating in the healthcare and technology sectors. The company offers a computerized testing solution, BrainCare, which provides objective tests across various cognitive areas, graphical reports of patient progress, and evidence-based recommendations for brain training to promote wellness. The primary customers of NeuroTrax are clinicians, patients and their families, and researchers in the healthcare industry. It was founded in 2000 and is based in Newark, New Jersey.

C
C2C

C2C is a medical device company developing a portfolio of medical devices.

P
Precision Light

Precision Light is a stealth-mode medical device company

V
Verifica BG

Verifica BG is a medical device making company.

C
Cardiola

Cardiola have designed a patented device, the m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient's home.

B
Bio2Medical

BiO2 Medical is a medical device manufacturer founded to design, develop, and manufacture a range of medical products in response to clinical needs. BiO2 Medical's current primary objective is to develop and commercialize the Angel Catheter for the prevention of Pulmonary Embolism related mortality and morbidity in critically ill patients worldwide.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.